HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher J Hawkey Selected Research

lumiracoxib (prexige)

5/2008Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.
7/2007Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study.
1/2006Gastrointestinal tolerability of lumiracoxib in patients with osteoarthritis and rheumatoid arthritis.
8/2004Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.
8/2004Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher J Hawkey Research Topics

Disease

8Crohn Disease (Crohn's Disease)
09/2017 - 06/2004
7Ulcer
11/2009 - 03/2002
5Rheumatoid Arthritis
01/2013 - 10/2002
5Osteoarthritis
01/2013 - 08/2004
4Myocardial Infarction
04/2022 - 08/2004
4Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 11/2005
4Hemorrhage
04/2022 - 02/2003
4Inflammation (Inflammations)
01/2017 - 11/2005
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2017 - 03/2002
3Pain (Aches)
01/2009 - 11/2005
3Arthritis (Polyarthritis)
07/2007 - 08/2004
2Stroke (Strokes)
04/2022 - 11/2020
2Gout
11/2020 - 07/2014
2Ulcerative Colitis
02/2004 - 03/2002
1Chronic Renal Insufficiency
04/2022
1Peptic Ulcer (Peptic Ulcers)
02/2022
1Acute Coronary Syndrome
11/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2015
1Rheumatic Diseases (Rheumatism)
07/2014
1Chronic Pain
01/2009
1Chronic Disease (Chronic Diseases)
01/2007
1Neoplasms (Cancer)
12/2005
1Esophageal Neoplasms (Esophageal Cancer)
11/2005
1Polyps
11/2005
1Diverticulitis
02/2003
1Colitis
03/2002
1Diarrhea
03/2002

Drug/Important Bio-Agent (IBA)

8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2013 - 10/2002
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2022 - 08/2004
5Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2008 - 08/2004
5lumiracoxib (prexige)IBA
05/2008 - 08/2004
5Naproxen (Naprosyn)FDA LinkGeneric
07/2007 - 10/2002
4Ibuprofen (Motrin)FDA LinkGeneric
07/2007 - 08/2004
3Biomarkers (Surrogate Marker)IBA
11/2020 - 08/2011
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2015 - 10/2002
3rofecoxib (Vioxx)FDA Link
11/2005 - 10/2002
2Allopurinol (Remid)FDA LinkGeneric
11/2020 - 07/2014
2Uric Acid (Urate)IBA
11/2020 - 07/2014
2FebuxostatFDA Link
11/2020 - 07/2014
2Capsules (Microcapsules)IBA
05/2008 - 03/2007
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2004 - 08/2004
1Anti-Bacterial Agents (Antibiotics)IBA
02/2017
1SteroidsIBA
01/2017
1Biological ProductsIBA
12/2015
1C-Reactive ProteinIBA
01/2015
1Xanthine OxidaseIBA
07/2014
1Celecoxib (Celebrex)FDA Link
01/2013
1RhamnoseIBA
05/2008
1Lactulose (Duphalac)FDA LinkGeneric
05/2008
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
05/2008
1AcidsIBA
01/2007
1Esomeprazole (Nexium)FDA Link
01/2007
1glutathione S-transferase M1IBA
12/2005
1CytokinesIBA
02/2004
1InterleukinsIBA
02/2004
1InterferonsIBA
02/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2004
1AntipyreticsIBA
08/2003
1Analgesics (Analgesic Drugs)IBA
08/2003
1Hemoglobins (Hemoglobin)IBA
02/2003
1Pharmaceutical PreparationsIBA
03/2002
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
03/2002
1Azathioprine (Imuran)FDA LinkGeneric
03/2002

Therapy/Procedure

9Therapeutics
11/2020 - 10/2002
5Stem Cell Transplantation
01/2017 - 06/2004
2Hematopoietic Stem Cell Transplantation
02/2017 - 12/2015
1Secondary Prevention
04/2022
1Immunotherapy
02/2017
1Transplantation
06/2004